BioBio schreef op 18 maart 2024 11:06:
Pharming Technologies B.V.; Treatment of activated phosphoinositide 3-kinase delta
syndrome (APDS)
Scope: Letter by the applicant dated 12.03.2024 requesting an extension to the clock stop
to respond to the list of outstanding issues adopted in January 2024.
Action: For adoption List of Outstanding Issues adopted on 2